No definition available.
Other congenital malformations of heart
DOID EFO Endpoint Browser PheWeb
Q17_OTHER_CONGEN_MALFO_HEART
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
246 |
4. Check minimum number of eventsNone |
246 |
5. Include endpointsNone |
246 |
6. Filter based on genotype QC (FinnGen only) |
246 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Aliae malformationes congenitae cordis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of heart
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2325 | 1187 | 1135 |
| Only index persons | 1745 | 915 | 830 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 10.16 | 13.47 | 6.64 |
| Only index persons | 16.61 | 21.73 | 10.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 246 | 145 | 101 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 20.25 | 23.75 | 15.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 223
- Matched controls
- 2228
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
42.7
58.9
73
25
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
52.5
56.6
67
18
201
Kela drug reimbursment
Chronic cardiac insufficiency
38.5
53.6
68
25
Q24.6
ICD-10 Finland
Congenital heart block
+∞
53.3
49
*
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
49.9
46
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
12.8
47.2
93
118
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
10.1
47.1
111
198
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
33.5
42.8
56
22
XF400
NOMESCO Finland
ECG with 12 standard connections
8.5
39.5
103
205
XF404
NOMESCO Finland
Ambulatory ECG
14.3
39.1
70
69
B01AA03
ATC
warfarin; systemic
13.2
38.1
71
76
C03CA01
ATC
furosemide; systemic
9.5
37.3
86
138
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
117.5
37.1
39
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
36.5
34
*
FM2CE
NOMESCO Finland
NA
17.0
35.5
58
45
Q24.0
ICD-10 Finland
Dextrocardia
+∞
35.3
33
*
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
35.3
33
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
42.7
34.2
42
12
C03DA01
ATC
spironolactone; oral
13.7
33.3
60
58
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
32.0
30
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
21.1
30.9
46
27
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
29.9
28
*
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
29.9
28
*
ZXE20
NOMESCO Finland
More than three and less than five hours
7.3
28.5
77
150
Z2221
NOMESCO Finland
Medical doctor
5.1
27.5
118
403
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
8.8
27.4
63
95
61
HP
Catheterization and pressure measurement of the left side of the heart
110.5
27.4
29
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
21.9
27.3
40
22
31
HP
Congenital heart failure surgery
+∞
26.6
25
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.8
26.5
127
479
ZXD10
NOMESCO Finland
Scheduled procedure
4.6
25.6
133
538
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
25.5
24
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
+∞
25.5
24
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.8
25.2
63
107
XF402
NOMESCO Finland
ECG with work load test
10.5
25.1
51
61
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
63.6
24.7
28
5
XF622
NOMESCO Finland
Measurement of minute volume of heart
63.6
24.7
28
5
I44.2
ICD-10 Finland
Atrioventricular block, complete
41.3
23.6
29
8
62
HP
Catheterization and pressure measurement of the right side of the heart
255.0
23.1
23
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
22.3
21
*
Q20.48
ICD-10 Finland
Single ventricle
+∞
22.3
21
*
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
22.3
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.2
21.5
115
453
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.0
21.4
65
142
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.3
21.1
49
73
C01AA05
ATC
digoxin; systemic
17.4
21.0
33
22
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
20.1
19
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
115.3
19.9
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.0
19.3
103
395
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
19.0
18
*
Q24.58
ICD-10 Finland
Malformation of coronary vessels
+∞
19.0
18
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
57.6
18.3
21
*
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
+∞
17.9
17
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
54.6
17.3
20
*
ZXD05
NOMESCO Finland
Urgent procedure
3.7
17.1
100
403
207
Kela drug reimbursment
Chronic arrhythmias
8.6
17.1
38
52
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
+∞
16.9
16
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
43.7
16.6
20
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.8
16.2
86
318
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.5
16.1
39
61
C07AB07
ATC
bisoprolol; oral
3.7
16.0
86
322
Z98.8
ICD-10 Finland
Other specified postsurgical states
28.7
15.9
21
8
Q24.50
ICD-10 Finland
Congenital coronary artery-coronary fistula
+∞
15.8
15
*
Q23.11
ICD-10 Finland
Bicuspid aortic valve
+∞
15.8
15
*
XF600
NOMESCO Finland
Bloodpressure measurement
5.5
15.4
48
105
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.1
15.1
43
84
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
14.7
14
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
14.7
14
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
24.2
14.5
20
9
WX882
NOMESCO Finland
High dependency care
5.6
13.9
42
88
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.7
13.9
36
62
G04BE03
ATC
sildenafil; oral
80.2
13.7
15
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
13.7
13
*
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
13.7
13
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
13.7
13
*
R4110
NOMESCO Finland
Physiotherapy
3.3
13.6
88
371
R07.4
ICD-10 Finland
Chest pain, unspecified
3.8
13.1
62
205
Z3231
NOMESCO Finland
Registered nurse
3.0
12.9
104
504
WX704
NOMESCO Finland
Intubation
6.1
11.9
33
62
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
11.6
11
*
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
11.6
11
*
I50.9
ICD-10 Finland
Heart failure, unspecified
6.5
11.5
30
52
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.0
11.1
23
28
ZXE00
NOMESCO Finland
One hour or less
2.6
10.7
115
646
I47.2
ICD-10 Finland
Ventricular tachycardia
15.2
10.7
17
12
C07AB02
ATC
metoprolol; systemic
4.0
10.5
44
129
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
11.4
10.5
19
18
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
10.5
10
*
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
+∞
10.5
10
*
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
10.5
10
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
10.5
10
*
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
10.5
10
*
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
+∞
10.5
10
*
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
+∞
10.5
10
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
10.5
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.4
10.5
57
207
RS224
NOMESCO Finland
NA
14.0
10.3
17
13
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
10.3
57
210
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
9.4
9
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
9.4
9
*
73
HP
Initial pacemaker installation
+∞
9.4
9
*
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
9.4
9
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
9.4
9
*
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
9.4
9
*
WX892
NOMESCO Finland
Monitored bed care
4.4
9.1
33
84
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
10.1
8.9
17
18
Z2446
NOMESCO Finland
Social worker
3.4
8.5
43
147
FM1CD
NOMESCO Finland
Very extensive CT of heart
93.4
8.5
9
*
FPF00
NOMESCO Finland
Implantation of epicardial pacemaker with ventricular electrode
93.4
8.5
9
*
C09AA02
ATC
enalapril; systemic
3.7
8.4
37
113
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
8.4
8
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
+∞
8.4
8
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
+∞
8.4
8
*
4260A
ICD-9 Finland
Conduction disorders, Atrioventricular block, complete
+∞
8.4
8
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
+∞
8.4
8
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
8.4
8
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
8.4
8
*
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
+∞
8.4
8
*
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
8.4
8
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
12.3
8.2
14
12
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
18.0
8.2
12
7
I42.0
ICD-10 Finland
Dilated cardiomyopathy
10.6
8.2
15
15
C07AA07
ATC
sotalol; systemic
23.0
8.1
11
5
I48
ICD-10 Finland
Atrial fibrillation and flutter
4.0
8.0
32
90
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
7.8
56
239
ZXA05
NOMESCO Finland
Left side
2.8
7.8
53
220
TFP20
NOMESCO Finland
Cardiodefibrillation
7.1
7.8
18
27
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.9
7.6
18
28
7AX01
NOMESCO Finland
NA
82.7
7.5
8
*
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
7.3
7
*
74619
ICD-8 Finland
Congenital anomalies of heart, Transposition of great vessels
+∞
7.3
7
*
Q25.3
ICD-10 Finland
Stenosis of aorta
+∞
7.3
7
*
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
7.3
7
*
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
7.3
7
*
ZX199
NOMESCO Finland
Other rote
16.4
7.3
11
7
Z94.1
ICD-10 Finland
Heart transplant status
31.1
7.2
9
*
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
31.1
7.2
9
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
10.5
7.1
13
13
I50.1
ICD-10 Finland
Left ventricular failure
10.5
7.1
13
13
ZX120
NOMESCO Finland
Intravenous
3.6
7.0
31
95
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
6.9
54
242
R50.9
ICD-10 Finland
Fever, unspecified
2.6
6.9
56
255
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.5
6.8
19
37
I49.5
ICD-10 Finland
Sick sinus syndrome
17.3
6.8
10
6
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
6.7
58
276
WX402
NOMESCO Finland
General anaesthesia
2.5
6.7
55
254
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.8
6.7
11
9
C01BD01
ATC
amiodarone; systemic
12.8
6.7
11
9
Z3226
NOMESCO Finland
Physiotherapist
2.4
6.6
62
308
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.6
50
222
FM1BD
NOMESCO Finland
Extensive CT of heart
71.8
6.5
7
*
602
Kela drug reimbursment
Children's severe malnutrition
5.7
6.3
17
32
FDJ00
NOMESCO Finland
End to end reconstruction of aorta for coarctation
+∞
6.3
6
*
Q26.8
ICD-10 Finland
Other congenital malformations of great veins
+∞
6.3
6
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
6.3
6
*
FLE00
NOMESCO Finland
Excision of subvalvular membrane of left ventricle
+∞
6.3
6
*
1EA01
NOMESCO Finland
NA
+∞
6.3
6
*
Q89.30
ICD-10 Finland
Situs inversus with dextrocardia
+∞
6.3
6
*
I45.8
ICD-10 Finland
Other specified conduction disorders
+∞
6.3
6
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
+∞
6.3
6
*
FFK20
NOMESCO Finland
Atrio-pulmonary anastomosis
+∞
6.3
6
*
81
HP
Angiography of the heart and coronary arteries
8.0
6.2
13
17
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
6.2
38
147
WX872
NOMESCO Finland
Intensive care
7.0
6.1
14
21
XX3BT
NOMESCO Finland
Other labeling with X-ray guidance
9.0
6.1
12
14
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.6
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
156
287
13.12
95.58
9.9
3.3
ng/l
861.1
854.0
0.01
149
232
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
44
17
31.30
64.81
3.8
3.4
%
76.6
114.4
3.36
44
17
(3032080) INR in Blood by Coagulation assay
154
496
6.63
48.69
15.4
5.1
inr
1.5
1.1
2.45
27
150
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
96
227
6.30
41.64
8.7
3.1
ng/l
3001.0
168.1
1.49
84
139
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
57
85
8.43
38.32
4.9
6.7
%
174.4
171.9
0.07
57
85
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
34
13.04
37.13
35.3
19.2
u/ml
0.3
0.3
0.55
20
22
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
123
420
4.86
33.57
3.6
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
135
528
4.45
30.08
3.8
3.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
74
7.02
26.14
28.1
18.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
100
361
3.98
23.90
6.6
3.4
mg/l
1.7
1.2
0.71
78
282
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
185
4.60
22.95
3.4
3.0
%
18.8
22.6
1.73
62
171
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
156
778
3.75
22.51
5.0
4.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
58
147
4.85
22.04
24.3
11.3
mmol/l
0.4
0.5
0.10
48
115
(3022217) INR in Platelet poor plasma by Coagulation assay
49
111
5.26
21.21
32.4
15.7
inr
2.0
1.3
—
5
20
(3044889) 12 lead EKG panel
177
1022
3.61
18.99
5.3
2.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
41
92
5.15
17.82
32.5
10.9
%
0.6
0.7
0.67
41
92
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
41
93
5.09
17.59
32.5
10.8
%
1.2
1.4
0.47
41
93
(3024928) Oxygen saturation in Venous blood
27
41
7.27
17.40
8.1
18.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
90
367
3.29
16.94
4.4
4.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
129
648
3.08
16.92
8.6
6.8
g/l
37.4
36.9
0.56
123
621
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
157
884
3.14
16.73
17.0
10.7
mmol/l
1.2
1.2
4.54
152
792
(3019230) Fractional oxyhemoglobin in Venous blood
25
38
7.21
16.07
7.4
18.6
%
71.3
69.1
0.23
25
38
(3003458) Phosphate [Moles/volume] in Serum or Plasma
78
322
3.08
14.04
15.2
10.5
mmol/l
1.3
1.2
0.62
73
306
(3013826) Glucose [Moles/volume] in Serum or Plasma
169
1058
2.91
13.70
15.0
6.5
mmol/l
6.2
6.3
0.10
157
968
(3000991) Gas panel - Venous blood
73
303
3.00
12.89
25.7
10.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
94
448
2.78
12.83
4.8
3.0
ng/l
85.5
23.9
0.87
55
242
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
72
309
2.88
11.86
20.6
13.9
mmol/l
24.7
24.7
0.04
72
309
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
139
840
2.51
11.25
12.9
7.1
umol/l
20.1
16.3
0.72
133
791
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
89
443
2.58
10.84
3.2
3.0
mg/l
3.1
3.0
0.06
81
391
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
51
191
3.11
10.62
1.8
1.9
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
10
0
+∞
10.49
4.1
0.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
255
2.85
10.43
1.8
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
54
212
2.98
10.34
2.6
2.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
233
1899
5.29
9.60
31.0
13.2
mmol/l
4.0
4.0
1.55
233
1840
(3000494) Fungus identified in Specimen by Culture
48
185
2.98
9.45
1.5
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
232
1896
4.93
9.27
31.0
13.2
mmol/l
139.4
139.6
0.58
232
1844
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
48
191
2.88
8.90
1.8
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
29
5.83
8.61
10.7
23.5
%
10.9
11.8
0.65
16
29
(3002032) Base excess in Venous blood by calculation
66
319
2.46
8.28
10.4
9.5
mmol/l
0.7
1.4
0.82
53
240
(3018418) pH of Serum or Plasma
80
425
2.31
8.09
3.5
4.0
ph
7.4
7.4
0.21
12
70
(3003694) ABO and Rh group [Type] in Blood
99
579
2.19
7.89
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
22
6.18
7.46
2.0
4.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
249
2.50
7.43
16.4
9.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
134
896
2.09
7.40
3.9
3.1
ug/l
87.3
71.9
0.55
129
841
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
39
4.61
7.08
1.4
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
19
49
4.12
6.85
5.2
12.2
mmol/l
21.0
23.7
3.67
19
43
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
288
2.33
6.74
16.7
9.0
mmol/l
1.6
0.7
2.05
46
207
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
58
292
2.29
6.51
16.8
8.9
kpa
4.9
5.0
0.93
58
274
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
8
12.96
6.13
1.3
1.4
%
119.1
124.8
—
10
8
(40758558) Short blood count panel - Blood
99
625
1.98
6.10
6.5
9.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
357
2.12
5.84
3.5
3.3
e6/l
1.0
0.7
0.73
37
201
(3018095) Leukocytes [#/volume] in Urine
108
713
1.92
5.76
5.0
4.5
e6/l
204.7
40.8
0.42
77
473
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
35
4.18
5.24
1.2
1.0
u/ml
1.5
1.5
—
6
15
(3012501) Base excess in Blood by calculation
11
23
4.96
5.06
2.6
4.3
mmol/l
1.6
2.7
—
6
16
(3027315) Oxygen [Partial pressure] in Blood
11
23
4.96
5.06
2.7
4.3
kpa
8.6
9.2
0.24
11
23
(3013290) Carbon dioxide [Partial pressure] in Blood
11
23
4.96
5.06
2.6
4.3
kpa
5.0
4.9
0.21
11
23
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
51
3.51
4.98
7.6
13.2
—
3087.1
—
0
8
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
229
2013
2.99
4.92
22.0
11.8
mg/l
23.2
22.0
0.25
192
1440
(3030467) Casts [#/volume] in Urine by Automated count
87
559
1.86
4.88
4.6
3.7
e6/l
0.4
0.3
0.20
66
397
(3007853) Bacteria identified in Skin by Aerobe culture
47
244
2.14
4.82
2.1
1.8
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
8
7
11.76
4.82
6.4
14.0
mmol/l
1.2
1.2
—
8
7
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
7
11.76
4.82
1.8
1.0
%
80.0
148.3
—
8
7
(3002582) Erythrocytes [#/volume] in Urine
92
606
1.83
4.74
4.4
3.8
e6/l
34.3
152.9
0.54
71
449
(3037467) Urinalysis macro (dipstick) panel - Urine
162
1268
1.81
4.61
5.7
4.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
97
655
1.79
4.57
5.1
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
231
2058
3.01
4.48
19.3
9.5
—
—
—
0
0
(3013512) EKG study
57
327
1.97
4.45
6.0
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
31
4.02
4.31
1.1
1.0
—
—
—
0
0
(4268621)
11
27
4.22
4.21
2.3
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
218
1905
2.27
4.17
32.1
15.8
g/l
333.3
334.3
1.02
218
1892
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
105
2.54
4.14
2.6
2.6
ml/min/173m2
77.0
80.0
—
9
45
(3013115) Eosinophils [#/volume] in Blood
150
1169
1.73
4.12
10.0
9.2
e9/l
0.2
0.2
0.00
138
1010
(36304419) Bacteria [Presence] in Urine
84
558
1.77
4.11
4.3
3.7
—
—
—
0
0
(3010421) pH of Blood
11
28
4.07
4.02
2.7
3.8
ph
7.4
7.4
0.58
11
23
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
33
3.77
3.97
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
65
2.91
3.95
4.6
10.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
147
1148
1.70
3.93
9.0
8.3
e9/l
0.6
0.6
0.41
134
971
(3006315) Basophils [#/volume] in Blood
147
1148
1.70
3.93
9.0
8.3
e9/l
0.0
0.0
0.27
134
974
(3019198) Lymphocytes [#/volume] in Blood
150
1178
1.70
3.93
8.9
8.4
e9/l
1.9
2.2
3.85
139
1022
(4034850)
14
44
3.31
3.84
13.5
8.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
111
809
1.68
3.83
10.3
9.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
71
459
1.77
3.77
4.0
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
60
369
1.83
3.76
4.1
3.1
mosm/kgh2o
592.9
574.5
0.22
50
307
(3000850) Epithelial cells [#/volume] in Urine
63
394
1.81
3.74
3.5
3.1
e6/l
6.5
6.4
0.01
56
338
(4306422)
10
25
4.13
3.73
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
25
4.13
3.73
4.3
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
79
530
1.72
3.67
4.5
3.2
mmol/l
2.4
2.4
0.12
74
485
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
348
1.83
3.65
3.6
3.4
e6/l
3.4
2.4
0.37
30
193
(3042733) HLA Ab [Presence] in Serum
8
13
6.32
3.53
3.6
2.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
6
10.21
3.51
6.3
10.5
mmol/l
1.2
1.3
—
6
6
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
177
1475
1.71
3.51
15.4
9.1
ml/min/173m2
97.2
93.9
1.07
145
1102
(3021601) Nitrite [Presence] in Urine by Test strip
119
900
1.62
3.45
5.8
4.8
estimate
0.0
0.0
0.00
17
163
(3035350) Ketones [Presence] in Urine by Test strip
119
901
1.62
3.42
4.1
3.4
estimate
0.0
0.0
0.00
18
160
(3024932) HLA-DR beta [Type]
9
18
5.15
3.40
1.1
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
9
18
5.15
3.40
1.1
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
71
472
1.71
3.38
4.4
3.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
65
2.74
3.38
2.3
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
65
2.74
3.38
2.1
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
119
908
1.60
3.27
4.1
3.4
estimate
0.0
0.0
0.00
17
157
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
19
4.87
3.27
3.7
5.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
88
2.39
3.03
1.7
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
132
1046
1.57
3.00
12.8
11.0
e9/l
0.0
0.0
0.50
106
793
(3006576) Bicarbonate [Moles/volume] in Blood
5
5
10.17
2.99
10.0
13.6
mmol/l
26.2
25.5
—
5
5
(3013650) Neutrophils [#/volume] in Blood by Automated count
154
1269
1.57
2.91
11.9
11.7
e9/l
3.8
3.7
0.05
141
1074
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
117
2.16
2.88
1.5
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
59
2.64
2.84
2.4
2.2
g/l
1.1
1.3
—
10
52
(3051611) Lipemic interference index of Serum or Plasma
10
31
3.32
2.80
4.6
3.1
—
—
—
0
0
(44790049)
12
42
2.95
2.79
2.5
2.4
—
—
—
0
0
(44806118)
12
42
2.95
2.79
2.5
2.4
—
—
—
0
0
(44790048)
12
42
2.95
2.79
2.5
2.4
—
—
—
0
0
(44790047)
12
42
2.95
2.79
2.5
2.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
45
2.75
2.49
5.0
4.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
52
345
1.64
2.45
4.5
4.0
mg/mmol
4.2
15.5
1.85
39
229
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
27
3.42
2.41
1.6
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
50
332
1.64
2.34
3.7
3.4
mg/l
19.9
305.8
0.84
35
229
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
28
3.30
2.33
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
64
452
1.56
2.32
4.2
3.7
estimate
0.0
0.0
0.50
18
157
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
47
2.63
2.30
1.5
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
54
2.49
2.24
1.8
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
9
5.64
2.22
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
160
1.85
2.21
8.9
5.0
e9/l
63.1
68.2
0.50
18
115
(3021901) Oxygen saturation in Capillary blood
9
30
3.07
2.17
1.9
8.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
647
1.48
2.16
4.2
3.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
43
2.63
2.12
1.3
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
34
209
1.73
2.12
3.8
3.9
g/l
9.1
9.1
0.02
34
198
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
148
1.85
2.08
5.7
6.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
20
3.57
2.07
2.3
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
20
3.57
2.07
1.0
1.0
%
85.1
95.6
—
7
20
(3038515) Glucose [Moles/volume] in Venous blood
8
26
3.14
2.03
4.0
3.2
mmol/l
6.3
7.4
—
8
26
(3007461) Platelets [#/volume] in Blood
239
2289
2.55
2.00
34.5
17.6
e9/l
247.2
264.2
3.73
239
2205
(3024731) MCV [Entitic volume]
239
2290
2.53
2.00
34.4
17.5
fl
88.6
88.4
0.23
239
2264
(4094501)
9
33
2.79
1.95
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
142
0.34
1.95
1.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
417
1.51
1.93
4.4
3.1
kg/l
1.0
1.0
—
9
72
(3035637) Corticotropin [Mass/volume] in Plasma
15
72
2.15
1.90
2.3
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
34
2.71
1.88
1.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
239
2293
2.49
1.87
37.3
17.6
g/l
134.3
135.1
0.35
239
2266
(3010813) Leukocytes [#/volume] in Blood
239
2292
2.50
1.87
34.5
17.5
e9/l
6.9
6.8
0.51
239
2196
(3035941) MCH [Entitic mass]
239
2291
2.52
1.86
34.4
17.4
pg
29.6
29.6
0.04
239
2264
(3026361) Erythrocytes [#/volume] in Blood
239
2291
2.52
1.86
34.5
17.5
e12/l
4.6
4.6
0.87
239
2201
(3010375) cycloSPORINE [Mass/volume] in Blood
7
23
3.10
1.81
17.9
53.5
ug/l
184.1
140.6
—
7
23
(40760892) CBC W Ordered Manual Differential panel - Blood
59
432
1.48
1.79
4.2
5.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
41
2.50
1.78
2.9
2.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
30
2.72
1.74
4.0
2.9
mmol/l
1.4
1.2
—
8
30
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
30
2.72
1.74
1.6
3.7
%
57.8
56.1
—
8
30
(40761535) Cells panel - Urine sediment
20
112
1.86
1.70
4.5
3.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
32
2.55
1.61
1.6
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
32
2.55
1.61
4.6
3.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
26
2.74
1.59
1.3
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
37
2.49
1.49
1.6
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
29
2.45
1.40
2.3
2.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
17
97
1.81
1.39
4.0
4.6
mmol/l
1.2
1.2
0.11
17
85
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
97
1.81
1.39
2.4
2.1
u/ml
204.2
168.8
0.17
12
52
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
320
1.46
1.38
1.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
68
1.96
1.36
4.1
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
129
1.69
1.35
3.3
5.6
%
0.1
0.0
—
7
35
(3034770) Mitochondria Ab [Titer] in Serum
11
54
2.09
1.35
1.5
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
23
145
1.65
1.34
3.9
5.2
%
2.7
0.7
—
8
49
(3002179) Metamyelocytes/100 leukocytes in Blood
21
130
1.67
1.31
3.4
5.2
%
1.4
0.4
—
7
31
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
460
1.37
1.26
1.5
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
132
1.65
1.25
3.8
5.6
%
0.5
0.1
—
8
42
(3040151) Glucose [Moles/volume] in Capillary blood
6
25
2.43
1.25
1.7
2.4
mmol/l
5.7
6.1
—
6
19
(36660697) Celiac disease serology panel - Serum
19
296
0.61
1.25
1.4
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
19
2.66
1.22
2.4
2.3
mmol/l
107.2
105.1
—
5
19
(3041354) Potassium [Moles/volume] in Venous blood
5
19
2.66
1.22
2.4
2.3
mmol/l
3.7
4.0
—
5
19
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
19
2.66
1.22
2.4
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
89
745
1.30
1.18
3.7
2.8
nmol/l
72.8
71.8
0.12
84
687
(3037522) Nuclear Ab [Titer] in Serum
37
269
1.44
1.18
1.5
1.4
titre
346.7
398.4
—
6
49
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
31
2.29
1.11
1.6
2.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
2036
1.44
1.11
15.3
9.2
u/l
28.1
25.7
1.62
215
1970
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
89
1.73
1.10
2.7
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
41
1.98
1.10
1.8
1.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
21
2.41
1.09
3.6
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.41
1.09
1.2
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
215
0.58
1.09
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
172
1578
1.30
1.08
4.6
3.5
mmol/l
1.4
1.5
1.63
172
1485
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
147
0.53
1.07
1.1
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
67
1.83
1.06
5.3
2.9
—
—
—
0
0
(4062490)
7
34
2.09
1.03
1.4
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
7
34
2.09
1.03
1.4
1.2
g/l
1.2
2.6
—
7
25
(3024139) IgG subclass 3 [Mass/volume] in Serum
7
34
2.09
1.03
1.4
1.2
g/l
0.3
0.4
—
7
25
(3027135) IgG subclass 1 [Mass/volume] in Serum
7
34
2.09
1.03
1.4
1.2
g/l
7.4
7.0
—
7
26
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
190
1.47
1.02
1.9
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
151
1370
1.26
1.00
4.4
4.3
mm/h
7.7
9.1
1.25
143
1284
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
3.4
2.0
umol/l
23.8
28.5
—
5
23
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
77
1.73
0.97
2.7
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
101
1.62
0.96
2.4
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
37
1.92
0.95
1.4
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
170
0.57
0.94
1.1
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
52
1.76
0.93
1.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
52
1.76
0.93
1.9
2.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
94
1.63
0.93
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
94
1.63
0.93
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
94
1.63
0.93
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
94
1.63
0.93
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
191
0.61
0.88
1.0
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
30
2.02
0.87
1.5
3.7
e9/l
6.3
4.1
—
6
30
(1761868) Lipid panel - Serum or Plasma
47
578
0.77
0.86
3.0
2.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
45
1.80
0.85
1.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
24
172
1.44
0.85
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
52
630
0.78
0.84
1.9
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
98
1.57
0.80
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
221
0.66
0.80
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
33
1.84
0.79
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
99
0.49
0.79
1.0
1.7
—
—
—
0
0
(4198724)
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
11.0
—
787.8
—
0
26
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
14.7
—
1333.4
—
0
26
(4035726)
18
124
1.49
0.77
2.9
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
59
1.72
0.77
2.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
59
1.72
0.77
2.2
1.4
—
—
—
0
0
(44813793)
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
53
1.72
0.76
1.1
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
53
1.72
0.76
1.9
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
54
1.69
0.75
1.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
100
1.53
0.74
2.4
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
109
0.54
0.74
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
117
1.49
0.74
1.9
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
39
1.82
0.73
1.9
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
25
2.02
0.73
6.8
4.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
208
1991
1.29
0.71
36.7
14.1
%
39.3
40.0
0.91
183
1691
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
26
1.94
0.71
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
110
1.49
0.70
2.6
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
160
1492
1.21
0.70
4.2
3.8
pmol/l
15.2
14.5
2.55
155
1391
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
43
1.65
0.67
2.3
2.5
g/l
143.3
134.1
—
7
30
(21494755) Public health laboratory ask at order entry panel
16
222
0.70
0.65
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
29
1.74
0.64
3.0
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
79
1.55
0.64
1.6
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
288
0.74
0.63
1.3
1.2
u/ml
1.0
9.9
2.44
12
113
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
61
702
0.83
0.62
1.5
1.6
u/ml
0.6
3.0
3.13
14
144
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
51
1.59
0.61
1.9
2.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.1
—
19.7
—
0
21
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
54
1.50
0.58
1.3
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
86
0.57
0.57
1.2
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
12
171
0.69
0.57
1.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
133
1.38
0.57
3.2
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
568
1.20
0.57
2.0
2.0
—
—
—
0
0
(3020891) Body temperature
8
55
1.47
0.56
9.9
5.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
180
0.71
0.53
1.1
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
366
0.79
0.53
1.6
2.9
ug/g
79.2
90.3
0.17
25
285
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
109
1.40
0.52
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
179
0.71
0.52
1.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
2.8
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
178
0.72
0.50
1.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
181
1.30
0.50
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
107
0.64
0.50
3.1
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
120
0.66
0.47
2.5
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.5
—
64.0
—
0
15
(3029075) Extractable nuclear Ab panel - Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
9.0
—
0.6
—
0
16
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
5.4
—
21.8
—
0
16
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.7
—
2.8
—
0
17
(3019225) pH of Specimen
7
104
0.66
0.40
3.6
6.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
67
1.36
0.38
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
53
472
1.16
0.38
3.0
3.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
69
1.32
0.37
1.6
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
179
0.77
0.37
1.1
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
41
1.47
0.36
2.8
1.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
6
42
1.44
0.36
6.2
3.5
—
604.0
—
0
7
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
43
1.41
0.35
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
44
1.37
0.34
1.2
1.1
—
11.5
—
0
8
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
136
1.27
0.34
3.4
2.2
u/l
9.0
6.9
—
10
92
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
26
222
1.19
0.31
3.5
3.7
%
23.9
23.6
0.04
12
92
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
74
0.67
0.26
1.6
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
96
1.26
0.25
2.0
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
528
1.10
0.23
2.0
1.7
pmol/l
82.1
96.8
2.09
32
268
(3005033) Fetal Nuchal fold Thickness US
10
79
1.28
0.22
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
79
1.28
0.22
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.6
1.6
nmol/l
0.3
0.3
—
5
34
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
407
0.89
0.22
2.3
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
35
316
1.13
0.22
1.5
1.4
nmol/l
18.9
21.3
0.55
30
267
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
42
1.19
0.21
1.2
1.4
u/ml
0.4
33.9
—
5
32
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
42
1.19
0.21
1.4
2.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
103
0.77
0.21
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
3.0
—
456.8
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
7.8
—
0
10
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
105
0.75
0.21
2.1
1.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
12
0.00
0.21
0.0
1.9
—
23.4
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
12
0.00
0.21
0.0
4.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
4.8
—
24.0
—
0
12
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
2.8
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
21.2
—
0
6
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
10.1
—
8.7
—
0
14
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
24.2
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
82
1.23
0.17
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
148
1.16
0.17
3.1
2.1
iu/l
9.3
16.6
1.29
11
114
(3004588) Protein electrophoresis panel - Serum or Plasma
7
63
1.11
0.17
1.3
2.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
68
0.73
0.17
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
69
0.72
0.17
2.2
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
69
0.72
0.17
1.6
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
78
1.16
0.15
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
295
1.10
0.15
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
103
1.17
0.14
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
209
1.11
0.13
2.0
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
113
1.16
0.13
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
148
0.87
0.13
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
95
1.17
0.12
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
172
1.11
0.12
2.4
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
157
0.89
0.11
1.3
1.3
iu/ml
146.1
179.6
—
5
60
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
181
1784
1.06
0.11
4.0
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
68
706
0.95
0.11
2.0
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
451
0.94
0.09
1.6
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
155
1.10
0.09
2.1
2.2
—
6.3
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
58
1.04
0.08
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
58
1.04
0.08
2.0
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
67
1.05
0.08
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
68
1.03
0.08
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
73
0.82
0.07
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
75
0.80
0.07
1.3
1.2
—
—
—
0
0
(4010399)
14
128
1.10
0.07
1.4
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
121
1224
0.98
0.04
4.4
3.4
u/l
54.4
36.5
2.08
116
1178
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
442
0.97
0.04
2.5
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
158
1567
1.02
0.03
4.5
3.4
mmol/l
5.8
5.7
0.78
150
1450
(3020961) Endomysium IgA Ab [Titer] in Serum
19
198
0.96
0.02
1.1
1.3
—
44.4
—
0
9
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
293
1.03
0.01
1.2
1.3
iu/ml
11.3
29.1
—
6
81
(3007164) IgA [Mass/volume] in Serum or Plasma
68
673
1.01
0.01
1.7
1.7
g/l
1.8
1.9
0.14
49
351
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
174
1.04
0.00
1.9
2.5
ug/l
0.5
0.8
2.98
12
101
(3025941) Bacteria identified in Stool by Culture
11
112
0.98
0.00
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
17
169
1.01
0.00
1.1
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
189
1.01
0.00
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
263
0.99
0.00
2.4
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
353
0.99
0.00
1.7
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
147
1.02
0.00
2.1
3.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
106
1.04
0.00
1.0
1.4
miu/ml
186.2
330.5
—
5
52
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
57
0.87
0.00
1.4
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
25.9
—
0
7
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
26.4
—
0
8
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
168.2
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.6
—
10.2
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
1.1
—
0
8
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
95.7
—
0
8
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
3.0
—
43.2
—
0
6
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
220.8
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
60
1.00
0.00
1.0
4.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
9
0.00
0.00
0.0
1.9
—
2350.0
—
0
9
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
173.0
—
0
6
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
7.8
—
0
8
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
50
1.00
0.00
1.4
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_HEART and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_HEART | 2.577 [1.84, 3.61] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.577 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 1004 females with Q17_OTHER_CONGEN_MALFO_HEART died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_HEART | 2.584 [1.86, 3.59] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 936 males with Q17_OTHER_CONGEN_MALFO_HEART died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_HEART.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.232% | 0.548% |
| 5 | 1.526% | 2.633% |
| 10 | 3.708% | 6.778% |
| 15 | 7.36% | 13.206% |
| 20 | 13.075% | 20.453% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_HEART – Other congenital malformations of heart
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data